Bispecific binding agents targeting IGF1R and ErbB3 signalling and uses thereof

Details for Australian Patent Application No. 2010306774 (hide)

Owner Dyax Corp. Merrimack Pharmaceuticals, Inc.

Inventors Schoeberl, Birgit; Nielsen, Ulrik; Kudla, Arthur J.; Muruganandam, Arumugam; Buckler, David; Lugovskoy, Alexey Alexandrovich; Fitzgerald, Jonathan Basil; Xu, Lihui; Kohli, Neeraj

Agent Davies Collison Cave

Pub. Number AU-A-2010306774

PCT Pub. Number WO2011/047180

Priority 61/251,426 14.10.09 US

Filing date 14 October 2010

Wipo publication date 21 April 2011

International Classifications

C07K 14/525 (2006.01) Peptides having more than 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/765 (2006.01) Peptides having more than 20 amino acids

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/32 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/047180 Priority application(s): WO2011/047180

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010306775-Novel multifunctional materials for insitu environmental remediation of chlorinated hydrocarbons

2010306768-Synthetic methods for spiro-oxindole compounds